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2	  
ABSTRACT 24	  
This work represents an investigation into the presence, abundance and diversity of 25	  
virus-like particles (VLPs) associated with human faecal and caecal samples. Various 26	  
methodologies for the recovery of VLPs from faeces were tested and optimized, including 27	  
successful down-stream processing of such samples for the purpose of an in-depth electron 28	  
microscopic analysis, pulsed-field gel electrophoresis and efficient DNA recovery. The 29	  
applicability of the developed VLP characterization method beyond the use of faecal samples 30	  
was then verified using samples obtained from human caecal fluid. 31	  
 32	  
Keywords: bacteriophages; microbial ecology; gastrointestinal tract; transmission electron 33	  
microscopy; caecum; faeces. 34	  
 35	  
 36	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3	  
1. INTRODUCTION 37	  
Viruses are the most numerous biological entities within the biosphere of our planet 38	  
(being present at an estimated number of ~1031), with bacteriophages representing the most 39	  
abundant group of environmental viruses [1, 2]. Bacteriophages are ubiquitous viruses that 40	  
infect bacterial cells and disrupt their metabolism. Multiple bacteriophage types can infect a 41	  
specific microbial isolate, with most bacteriophages infecting only certain species or even 42	  
strains of bacteria [3]. 43	  
Although they are abundant and potentially important to microbial populations 44	  
indigenous to different ecological niches within the human gastrointestinal tract and to host 45	  
health, little attention has been paid to bacterial virus-like particle (VLP) assemblages and 46	  
their interactions with the gastrointestinal microbiota and/or human host until recently. 47	  
Various publications have highlighted the potential importance of bacteriophages in 48	  
inflammation states, including Crohn’s disease [4, 5, 6], and as therapeutic agents [7, 8]. 49	  
Breitbart et al. [9] conducted the first metagenomic study on dsDNA-containing VLPs 50	  
associated with the human faecal virome using a fresh sample from a healthy adult male. On 51	  
the basis of previous estimates of gut microbial diversity, Breitbart et al. [9] predicted that 52	  
there are two to five times more viral genotypes (~1,200 viral genotypes) present in the 53	  
human gastrointestinal microbiota than the number of bacterial species, with the vast majority 54	  
of these VLPs representing bacteriophages and prophages. RNA viruses present in human 55	  
faeces have been found to be mostly associated with plant viruses, such as Pepper Mild 56	  
Mottle Virus, with RNA bacteriophages making a minimal contribution to the diversity of the 57	  
intestinal virome [10]. Using frozen samples from four adult female monozygotic twins and 58	  
their mothers, Reyes et al. [11] demonstrated that each individual harbours a unique virome 59	  
(ssDNA and dsDNA) regardless of their genetic relatedness to another individual, and that 60	  
intrapersonal virome diversity is very low, with >95 % of virotypes retained over a one-year 61	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4	  
period (between 71 and 2,773 viral genotypes identified among the samples). More recently, 62	  
Minot et al. [12] confirmed inter-individual variation in the virome and, similar to 63	  
modulation of the faecal bacteriome by foodstuffs, demonstrated that diet influences host 64	  
faecal virome structure. Minot et al. [13] also confirmed the relative stability of an 65	  
individual’s virome, monitoring 24 faecal samples from one individual over a 2.5-year 66	  
period. 67	  
The murine virome has been used to demonstrate enrichment of bacteriophage-68	  
encoded, antibiotic-resistance genes (related and unrelated to the drug used) after antibiotic 69	  
therapy, with the adaptive capacity of the virome (specifically its bacteriophage component) 70	  
suggested to protect gut bacteria, thereby preserving the microbiota’s robustness during 71	  
antibiotic stress [14]. 72	  
It is clear from the aforementioned studies that the virome–bacteriome community in 73	  
the gut is governed by complex and dynamic interactions in health, and that its balance may 74	  
be disturbed when under stress, e.g. during antibiotic intervention [14]. Although 75	  
metagenomic studies have greatly improved our understanding of the virome associated with 76	  
the human and murine gut microbiomes, it has been notable how little bacteriophage 77	  
material, and consequently DNA, has been isolated from samples when this information was 78	  
included in a publication. Reyes et al. [11] reported the isolation of ~500 ng DNA from 2 to 5 79	  
g of frozen faeces, whereas Thurber et al. [15] stated that between 500 and 3000 ng of DNA 80	  
could be isolated from 500 g of human faeces, though the publication they cite [9] provides 81	  
no information regarding the amount of DNA isolated from the 500 g faecal sample 82	  
examined in the original study. In addition, to the best of our knowledge, no attempts have 83	  
been made to enumerate bacteriophages in faecal filtrates prior to CsCl purification. The aims 84	  
of this study were to develop reliable and effective methods for the recovery and 85	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5	  
characterization of VLPs in human samples, and to apply these methods to human faecal and 86	  
caecal samples to demonstrate the methods’ efficiency. 87	  
88	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6	  
2. MATERIALS AND METHODS 88	  
2.1 Processing of and isolation of VLPs from faecal and caecal samples 89	  
Faecal samples were obtained from six healthy adult (2 male, 4 female) donors of 90	  
between 23 and 52 years of age, all of whom were members of the Department of Food and 91	  
Nutritional Sciences, University of Reading. None of the donors had taken antibiotics, 92	  
prebiotics and/or probiotics in the 3 months prior to sampling, and none had any history of 93	  
gastrointestinal disorder. All donors gave informed oral consent for their faecal samples to be 94	  
used for microbiological analyses. Ethical approval for the collection of caecal effluent from 95	  
patients was obtained from St Thomas’ Hospital Research Ethics Committee (06/Q0702/74) 96	  
covering Guy’s and St Thomas’ Hospitals and transferred by agreement to London Bridge 97	  
Hospital. Where available, clinical information for the colonoscopy patients is given in the 98	  
text. Samples were collected at Reading (faeces) or transported from St Thomas’ Hospital 99	  
(caecum), and maintained under anaerobic conditions (faeces, MACS1000 anaerobic 100	  
workstation, Don Whitley Scientific, gas composition 80 % N2, 10 % H2, 10 % CO2; caecum, 101	  
on ice in a gas jar with an anaerobic gas-generating pack; Oxoid Ltd) for a maximum of 2 h 102	  
before processing. Caecal samples were collected during routine colonoscopy following 103	  
preparation of the bowel with sodium picosulphate and a reduced fibre diet for 3 days. Liquid 104	  
residue in the caecum was aspirated via the colonoscope suction channel into a standard 30 105	  
ml trap specimen container and immediately transferred to a gas jar.  106	  
Faecal homogenates (20 %, w/v, from 25 g of faecal material) were prepared in sterile 107	  
TBT [0.1 µm filtered prior to autoclaving; 100 mM Tris/HCl, pH 8.0; 100 mM NaCl; 10 mM 108	  
MgCl2.6H2O] or sterile 0.5 % ‘Lab-Lemco’/6 % NaCl (LL [16]). Caecal homogenates (20 %, 109	  
v/v, from 10 to 30 ml of caecal effluent) were prepared in LL. Faecal and caecal samples 110	  
were placed into a filter stomacher bag and homogenized in a Stomacher 400 Lab System 111	  
(Seward) for 120 s at low speed. The bag was removed from the stomacher and massaged 112	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7	  
manually to further disperse any large particles remaining in the sample; the sample was then 113	  
stomached for a further 120 s. The homogenate was kept on ice for 2 h to allow desorption of 114	  
VLPs from solid material, then centrifuged at 11,180 g for 30 min at 10ºC. The supernatant 115	  
was transferred to a fresh tube and centrifuged again at 11,180 g for 30 min at 10ºC. 116	  
Supernatant [herein referred to as faecal filtrate (FF) for both faecal and caecal samples] was 117	  
passed through sterile 0.45 µm cellulose acetate filters (Millipore) and the FF was then 118	  
collected in a sterile container. An aliquot (10 µl) of each of the FFs was examined by 119	  
epifluorescence microscopy (EFM) after viral particles had been stained with SYBR Gold 120	  
(see below) to confirm that the samples were free of bacteria. 121	  
FF prepared in LL was used for enumeration of VLPs in faeces via EFM (see below) 122	  
and 1 ml aliquots of FF prepared in TBT were for examination by transmission electron 123	  
microscopy (TEM; see below). 124	  
Aliquots of FF and LL (two sets of three aliquots of 100 µl each: one for aerobic 125	  
cultivation, one for anaerobic cultivation) were spread onto Columbia blood agar containing 126	  
5 % laked horse blood (Oxoid), and incubated aerobically and anaerobically. Sterility of the 127	  
filtrates was confirmed by the absence of microbial growth on plates following incubation for 128	  
2 (aerobic) and 5 (anaerobic) days. Sterile brain–heart infusion broth was inoculated with 100 129	  
µl of FF and LL, and incubated aerobically for 2 days: aliquots (100 µl) were spread in 130	  
triplicate on plates to confirm sterility of the broth cultures. In addition, 10-ml aliquots of FF 131	  
were stored at 4°C for 6 months after collection, and were found to be free of bacteria when 132	  
checked (by plating) at monthly intervals. 133	  
Poly(ethylene glycol) (PEG; BioUltra, 8000; Sigma) was added to 2 × 20 ml aliquots 134	  
of the LL-prepared 0.45 µm-filtered FFs (final concentration of PEG, 10 %, w/v). The 135	  
samples were shaken gently to dissolve the PEG, then left at 4°C for 16 h ([16] used 16 h as 136	  
they observed an improved recovery of RNA bacteriophage compared to shorter incubations; 137	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8	  
[17] used 10 h, as they determined this to be longer than the minimum time required to obtain 138	  
a constant and stable white layer of viral precipitate). PEG-precipitated VLPs were then 139	  
harvested by centrifugation at 4,500 g for 30 min in a swing-out-bucket rotor at 4°C. The 140	  
supernatant was removed and the pellet resuspended in 1 ml TBT for pulsed-field gel 141	  
electrophoresis (PFGE) or 5 ml TBT for purification of VLPs on a CsCl gradient [15] with 142	  
ultracentrifugation performed at 100,000 g for 2 h at 10°C in a fixed-angle Type 50 Ti rotor 143	  
(Beckman Coulter). VLPs recovered by CsCl (1.35 and 1.5 g/cm3 fractions) were dialysed 144	  
(12,000 Da cut-off) twice against 400 ml sterile TBT, passed through a sterile 0.45 µm 145	  
cellulose acetate filter and stored at 4°C until DNA was extracted. An aliquot (5 µl) of each 146	  
of the CsCl-purified samples was viewed using EFM after viral particles had been stained 147	  
with SYBR Gold (see below) to confirm that the samples were free of bacteria. 148	  
 149	  
2.2 Epifluorescence microscopy (EFM) 150	  
A combination of the methods of Thurber and Patel [15, 18] was used to prepare FFs 151	  
(faecal only) for EFM. VLPs present in FF were not fixed in paraformaldehyde prior to 152	  
enumeration, as Wen et al. [19] showed that aldehyde fixation leads to a rapid loss in viral 153	  
abundance. The SYBR Gold concentration of 1–5× recommended by [15] did not work with 154	  
FFs; therefore, the 400× concentration recommended by [18] for use with planktonic aquatic 155	  
samples was used in this study. 156	  
The filtration system (see [15] for specifics of the set-up employed), including a 157	  
glass-graduated column, for collecting VLPs on filters was cleaned using 5 ml of 0.1 µm-158	  
filtered, sterile H2O and 5 ml of 0.1 µm-filtered ethanol. A sterile pair of flat-tipped forceps 159	  
was used to remove a 0.02-µm white Anodisc 25 membrane (Whatman) from its box, and the 160	  
filter was fitted to the glass frit of the filtration system under a low vacuum [<10 psi (~62 161	  
kPa)]. Duplicate 2 ml aliquots of 0.1 µm filtered, sterile H2O and 10 µl of sterile LL in 2 ml 162	  
Accepted version of Hoyles et al. (2014) Res Microbiol 165, 803–812. doi:10.1016/j.resmic.2014.10.006. 
	  
	  
9	  
0.1 µm filtered, sterile H2O were used as negative controls (to assess whether there was any 163	  
contamination in the water, the LL, the filter tower or the filter surface) and passed through 164	  
filters under low vacuum before any of the FF aliquots were filtered in duplicate. For each 165	  
sample, a 10 µl aliquot of 0.45 µm-filtered FF was added to 2 ml of the 0.1 µm filtered, 166	  
sterile H2O and the suspension gently mixed. The diluted sample was then introduced into the 167	  
filter system with the low vacuum maintained. The liquid was passed through the filter, and 168	  
VLPs were collected on the filter. The clip and glass column were carefully removed from 169	  
the filtration system and the filter was gently removed from the glass frit (still under 170	  
vacuum). While holding the filter with a forceps, the back of the filter was gently blotted dry 171	  
on a clean Kimwipe; the filter was then left to dry on a Kimwipe in a sterile Petri dish for 10 172	  
min in a dark box. The filtration system was cleaned with 5 ml of 0.1 µm-filtered, sterile H2O 173	  
and 5 ml of 0.1 µm-filtered ethanol, and the next sample processed. 174	  
Filters were stained with 100 µl droplets of 400× SYBR Gold and dried as described 175	  
by [18], prior to being applied in pairs to sterile glass slides. The mountant (20 µl per 176	  
coverslip) ProLong® Gold antifade reagent (Invitrogen) was added to 25 mm glass coverslips. 177	  
Coverslips were picked up with sterile forceps, inverted and placed on the Anodisc filters on 178	  
the microscope slides. Slides were then left at room temperature in the dark for 16 h to allow 179	  
the antifade to cure. Slides prepared in this manner can be stored at room temperature for 1 180	  
week or at 4ºC for 2 months. 181	  
Slides were viewed at 1000× magnification under a Nikon Microphot-SA microscope 182	  
fitted with a B-2A (blue excitation) filter and attached to a CoolSNAP-Pro MONOCHROME 183	  
(Media Cybernetics Inc.) camera. Images were captured using Image-Pro PLUS version 184	  
4.5.0.19 (Media Cybernetics Inc.), and VLPs in 25 fields of view were enumerated by eye. 185	  
The number of VLPs per millilitre of FF was calculated using the following equation: mean 186	  
number of VLPs in 25 fields of view × 100 × 25760.205; where 100 represents taking the 187	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10	  
sample back to per millilitre FF and 25760.205 represents the number of fields of view on a 188	  
filter. To give an estimate of the number of VLPs per gram of faeces, results were multiplied 189	  
by a factor of 5. The detection limit of the method was 1.03×105 VLPs/ml FF or 5.15×105 190	  
VLPs/g faeces. 191	  
 192	  
2.3 TEM of FFs (faecal and caecal) 193	  
Aliquots (1 ml) of FF prepared in TBT (faeces) or LL (caecum) were used for TEM 194	  
analysis within 1 week of collection: these filtrates had not been concentrated using PEG. 195	  
Carbon films (~3×3 mm in size) were floated from mica-sheets into a drop of filtrate (100 196	  
µl). After an adsorption time of 5–10 min, samples were transferred into a drop of 1 % (v/v) 197	  
of EM-grade glutaraldehyde (20 min) and subsequently into a drop of 2 % (w/v) uranyl 198	  
acetate for negative staining (1–2 min). After two washes for a few seconds in drops of 199	  
distilled water, samples were picked up with 400-mesh copper grids (Plano, Wetzlar, D). 200	  
Electron micrographs were taken in a Tecnai 10 transmission electron microscope (FEI 201	  
Company, Eindhoven, the Netherlands) at an accelerating voltage of 80 kV. Digital 202	  
micrographs were taken with a Megaview G2 CCD camera (Olympus SIS, Münster, 203	  
Germany). For estimation of VLP titers on the EM grids, a freshly prepared Lactococcus 204	  
lactis bacteriophage preparation with defined titer and unique morphology (i.e. prolate-205	  
headed bacteriophage P001 [20]) was added in concentrations of 107 and 108 plaque-forming 206	  
units (pfu) per ml to the faecal sample of donor 2 (with highest bacteriophage titer according 207	  
to TEM analysis). 208	  
 209	  
2.4 PFGE 210	  
Aliquots (40 µl) of PEG-precipitated samples resuspended in 1 ml TBT were used for 211	  
PFGE. These were heated at 60 or 75°C as appropriate. An aliquot (25 µl) of each heated 212	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(viscous) suspension and loading dye (5 µl) were combined and loaded into wells, which 213	  
were sealed with molten agarose. Run conditions for PFGE were as described by Fuhrman et 214	  
al. [21]: a 1 % agarose gel (SeaKem LE agarose) was made in 0.5× TBE [250 ml of 5× TBE 215	  
buffer (27 g Sigma 7–9, 13.75 g boric acid, 5 ml 0.5 M EDTA, 500 ml of H2O) added to 2.25 216	  
l H2O] and a CHEF DR II apparatus (Bio-Rad) was run for 18 h at 6 V and 14°C in 0.5× 217	  
TBE, with a 1–10 s switch time. Gels were stained with ethidium bromide (5 µg/ml) for 20 218	  
min and destained in distilled H2O for 10 min, or with 1× SYBR Gold (Molecular Probes) 219	  
made in 0.5× TBE. Bands of DNA were visualized under UV light (ethidium bromide) or 220	  
using a Dark Reader DR89X Transilluminator (Integrated Scientific Solutions Inc.) (SYBR 221	  
Gold). 222	  
 223	  
2.5 Isolation of DNA from CsCl-purified VLPs 224	  
DNA was extracted from 500 µl portions of CsCl-purified VLP samples according to 225	  
[15]. Prior to extracting DNA from purified VLPs, samples were treated with 20 µl of 1 226	  
mg/mL DNAse I (from bovine pancreas, 552 Kunitz/mg protein; made in water passed 227	  
through a 0.1 µm filter prior to autoclaving) for 1 h at 37°C, and were then heated at 80°C for 228	  
10 min to inactivate the DNAse prior to DNA extraction. DNA was air-dried and 229	  
resuspended in 50 µl of TE buffer. Sterility of samples (i.e. absence of bacterial DNA) was 230	  
confirmed by negative PCR from samples (10 µl) with universal primers [22]. DNA from an 231	  
in-house strain of Bifidobacterium longum (4-FAA1; [23]) was used as a positive control; 232	  
sterile water was used as the negative control. 233	  
234	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12	  
3. RESULTS AND DISCUSSION 234	  
3.1 Examination of VLPs in FFs (faeces) by using EFM 235	  
Previous studies examining the faecal virome have used 0.22 µm filters to prepare 236	  
samples [9, 11, 12, 13]. Preliminary work performed with 0.45 µm-filtered faecal samples 237	  
and 0.45 µm-filtered samples originating from in vitro fermentation systems inoculated with 238	  
faeces stained with 4ʹ′,6-diamidino-2-phenylindole (DAPI) and viewed under an 239	  
epifluorescence microscope suggested that the abundance of dsDNA VLPs in intestinal 240	  
samples was high, and that these particles can be enumerated (unpublished observations). 241	  
Contamination by bacteria was not observed in any of these samples, and confirmed by an 242	  
absence of cultivable bacteria and no bacteria in TEM analyses, so we decided to continue 243	  
using larger-pore filters for processing samples. Klieve & Swain [24] had previously used 244	  
0.45 µm-filtered samples to characterize VLPs present in rumen contents, and reported no 245	  
problems with contamination by bacteria. 246	  
To examine the VLPs present in FFs (faeces) by EFM, the method described by [9] 247	  
and [15] was used initially. However, it was found that we were unable to visualize many, if 248	  
any, VLPs present in the samples using 1–5× SYBR Gold as the DNA/RNA stain. Increasing 249	  
the concentration of SYBR Gold to 400×, as used by [18] for planktonic aquatic samples, 250	  
allowed us to enumerate and detect VLPs present in the FFs prepared from faecal samples of 251	  
six donors (Fig. 1 and Fig. 2). The samples were extracted in LL, though the method worked 252	  
as well with samples extracted in TBT (data not shown). To determine the relative abundance 253	  
of the predominant VLP morphologies in FFs, samples were not concentrated by CsCl 254	  
centrifugation (Fig. 1). All FFs were found to be free of bacteria by EFM (Fig. 2), with the 255	  
number of VLPs present in samples ranging from 2.4×108 to 1.12×109 VLPs/ml FF (mean 256	  
5.58×108 VLPs/ml FF) (equivalent to ~1.2×109 to 5.58×109 VLPs/g faeces, mean 2.94×109). 257	  
Lepage et al. [4] enumerated VLPs in gut mucosal samples from 14 healthy individuals and 258	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19 Crohn’s disease patients and found on average 1.2×109 VLPs/biopsy (range 4.4×107–259	  
1.7×1010), in agreement with the mean value we present here for faecal VLPs. Of note, 260	  
Crohn’s disease patients harboured significantly (P = 0.024) more VLPs than healthy 261	  
individuals (2.9×109 vs 1.2×108 VLPs/biopsy) in the study of Lepage et al. [4]. 262	  
It is generally accepted that there are around 10 bacteriophages for every microbial 263	  
cell in environmental samples investigated to date [25]. Extrapolating this figure to the gut 264	  
microbiota, from fluorescence in situ hybridization studies it is estimated that the faecal 265	  
microbiota harbours ~1011 bacteria/g faeces in healthy adults [26]. Consequently, one would 266	  
expect the presence of at least 1012 VLPs/g faeces. Enumerating VLPs in faeces via FFs (or 267	  
any liquid medium) by EFM is highly subjective as a dot of very intense fluorescence may in 268	  
fact represent a cluster of VLPs (Fig. 2), a phenomenon frequently encountered during this 269	  
study. Patel et al. [18] stated that, to accurately enumerate VLPs by EFM, micro-adjustments 270	  
using the fine focus of the microscope have to be made to ensure that all viruses in a 271	  
particular grid-reticle box are counted. We agree with this statement, and furthermore add 272	  
that many VLPs have very likely been lost during the preparation and filtering of samples, 273	  
either by association with debris in the initial centrifugations or by being caught in the filters 274	  
because of clogging or because the VLPs are too big to pass through the pores (e.g. members 275	  
of the order Megavirales [27]). Even after centrifugation, the supernatants from several of the 276	  
samples, while appearing relatively translucent, were highly viscous (perhaps due to host 277	  
mucins) and clogged the 0.45 µm filters with less than 2 ml of sample being filtered. 278	  
Consequently, the values we provide for the numbers of VLPs in FFs and faecal samples are 279	  
a conservative estimate. We believe the true number of VLPs present in faeces to be higher, 280	  
possibly between 1010 and 1012 VLPs/g faeces. Lepage et al. [4] determined there to be 1010 281	  
VLPs/mm3 tissue in their study of mucosal VLPs. 282	  
 283	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3.2 Examination of VLP diversity in FFs by the use of TEM 284	  
VLPs were readily detected in the TBT-extracted faecal samples from all donors by 285	  
TEM. Bacterial cells were never observed in any samples examined by TEM (limit of 286	  
detection 106 per ml). It was striking how visibly different/distinct the VLP assemblages were 287	  
between the donors, with no two donors sharing the same VLPs, at least on the basis of 288	  
morphological appearance (Fig. 3 and Fig. 4; Supplementary Fig. 1). The vast majority of 289	  
VLPs present in the samples appear to represent bacteriophages. Donor 1’s VLP assemblage 290	  
was predominated by small and large isometric-headed Siphoviridae with various tail length 291	  
sizes (approx. 120 nm, 350 nm, 650 nm, or, in one extreme case, 1220 nm), with some small 292	  
and large isometric-headed Myoviridae also present (Fig. 3a). Notably, donor 2’s VLP 293	  
assemblage was more diverse, predominated by numerous different morphotypes of 294	  
Myoviridae with Siphoviridae also present (Fig. 3b). Interestingly, two detached Myoviridae 295	  
tails of extreme length (480 nm) and thickness of the sheaths (40 nm) indicated the presence 296	  
of giant Myoviridae phages (Fig. 3b). Sime-Ngando et al. [28] have reported isolation of 297	  
bacteriophages with tails of 400 nm in length (heads 50–130 nm) from hypersaline lake 298	  
samples, though images of these large bacteriophages are unavailable for direct comparison 299	  
of the tails’ structures with those found in this study. Donor 2’s faecal sample contained 300	  
distinct small isometric-headed Myoviridae phages with uncommon radial fibers (approx 150 301	  
nm in length) attached to the capsids (~70 nm diameter) (Fig. 4). These fibers are clearly 302	  
extending the 110-nm tails of these phages, suggesting a primary role in bacteriophage 303	  
adsorption. This unique bacteriophage morphotype was also documented in low numbers in 304	  
Donor 4’s faecal sample (not shown), and in caecal samples L16 (not shown) and L18 305	  
(Supplementary Fig. 2d). Fig. 4 also illustrates the apparent clustering of Myoviridae phages 306	  
in samples. VLPs of various morphotypes derived from Donors 3, 4, 5, and 6 are shown in 307	  
Supplementary Figure 1a–d. “Zeppelin”-like VLPs of constant thickness (56 nm) but 308	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different lengths (370–630 nm) were detected in Donor 5 (Supplementary Fig. 1c) and Donor 309	  
6’s samples (Supplementary Fig. 1d). Donor 6’s sample was predominated by these 310	  
“zeppelin”-like VLPs, with only a few bacteriophages detected. Sime-Ngando et al. [28] 311	  
reported the presence of rods of up to 22–24 ×1000 nm: similar to the ‘zeppelins’ identified 312	  
in the present study, these rods had no visible internal or external structures. The largest 313	  
Myoviridae phages found in this study were documented for the sample of Donor 5 314	  
(Supplementary Fig. 1c), with the phages having prolate heads of 150 × 115 nm and tails of 315	  
400 nm in length. The sample from Donor 6 did not reveal the same level of diversity as seen 316	  
for the other faecal samples and the reason for this is not known (Supplementary Fig. 1d). 317	  
Enumeration of VLPs in the sample of Donor 2 (highest number of VLPs as detected by 318	  
TEM) demonstrated there to be approx. 5×107 VLPs/ml FF. 319	  
For the majority of the caecal samples, a lower extent of viral biodiversity was 320	  
documented. Sample L10 (no clinical data) was unique, containing exclusively small 321	  
isometric-headed Podoviridae (50 nm diameter) and ~20-nm long appendages (Fig. 5b). 322	  
Samples L08 (healthy) (Fig. 5a), and L02 and L03 (both IBD) (Suppl. Fig. 5b, c) appeared to 323	  
exclusively contain Myoviridae phages. The greatest extent of morphological variation and 324	  
the highest bacteriophage numbers were seen in caecal samples L16 (no clinical data) and 325	  
L17 (no clinical data) (Fig. 5c, d) and – to a lesser extent – in samples L01 (diverticulosis) 326	  
and L18 (no clinical data) (Supplementary Fig. 2a, d). A new type of a giant Myoviridae 327	  
bacteriophage was exclusively found in sample L16 (Fig. 5c) with isometric heads of 125 nm 328	  
in diameter, with tails of 340 nm in length and unique “curled” tail fibers of ~70-nm in 329	  
length.  330	  
Lepage et al. [4] demonstrated that gut mucosal samples were predominated by 331	  
morphotypes consistent with Siphoviridae, Myoviridae and Podoviridae, and that each 332	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individual appeared to be colonized by one dominant bacteriophage family. Our TEM results 333	  
for faecal and caecal VLP assemblages are consistent with these results. 334	  
 335	  
3.3 PFGE of VLPs present in FFs 336	  
It was clear from the EFM and TEM analyses that, based on the number of VLPs 337	  
present in our samples, it should be possible to isolate large amounts of VLP-derived DNA 338	  
from faeces. Attempts to recover abundant VLP DNA from samples using the centrifugation 339	  
method of Thurber et al. [15], and which was used by [9] and [11] to isolate VLP DNA from 340	  
faecal samples, proved disappointing in terms of the recovered DNA yield. However, 341	  
increasing the centrifugation speed to 100,000 g, routinely used in the laboratory to purify 342	  
lactococcal bacteriophages for preparation of high-quality DNA and used by Kulikov et al. 343	  
[29] to recover bacteriophages from horse faeces, markedly improved recovery of faecal 344	  
VLPs. 345	  
To concentrate VLPs from 20-ml quantities of FF so that they could be applied to 346	  
CsCl gradients in 5 ml aliquots, it was decided to use PEG precipitation. This method of 347	  
recovery has previously been used with, for example, marine samples and faecal samples to 348	  
improve detection of F-specific coliphages in faecal material [16, 17], and allows large 349	  
starting volumes of sample to be used for recovering VLPs from human faeces. The method 350	  
can be scaled easily so that the VLPs from larger volumes of FF are precipitated for 351	  
collection by centrifugation: we used 20 ml of FF from each donor here to demonstrate the 352	  
efficacy of the method, but the entire FF derived for each donor’s 25 g of starting material 353	  
could have been used for PEG precipitation of VLPs. 354	  
PEG-precipitated samples resuspended in 1 ml TBT were examined using PFGE. 355	  
Aliquots (40 µl) of the resuspended pellets were heated at 60°C [9] or 75°C ([24] used this 356	  
temperature to inactivate nucleases) before PFGE. Profiles containing one or more bands 357	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were observed for samples from all donors (Fig. 6). Following treatment at 60ºC, Donor 1’s 358	  
sample produced a faint band at 105 kb, with this band being more prominent following 359	  
sample treatment at 75ºC; at the higher temperature, bands were also observed at 135 kb and 360	  
just below 48.5 kb, with the most prominent band at 79 kb. Donor 2’s 60ºC-treated sample 361	  
produced a profile with a faint smear and a thin band at 84 kb; with the 75ºC-treated sample, 362	  
the smear was more pronounced, with a thick band observed between 75 and 84 kb. Similar 363	  
to Donor 2, the smear in Donor 4’s sample became more pronounced following treatment at 364	  
the higher temperature. For Donor 3’s 60ºC-treated sample, two strong bands (at 66 and 97 365	  
kb) were observed; in the 75ºC-treated samples, bands were observed at 57 kb, 75 kb and 97 366	  
kb. The profile of Donor 5 was most affected by changing the temperature at which samples 367	  
were treated prior to loading on the gel: the 60ºC-treated sample had three bands visible 368	  
(most prominent at 100 kb, fainter bands at 48.5 kb and 66 kb), whereas the 75ºC-treated 369	  
sample had these three bands with at least another 8 bands visible between 48.5 and 97.0 kb. 370	  
Donor 6’s sample had a faint band just below 48.5 kb after heating at 60ºC, whereas the 371	  
sample heated at the higher temperature produced two prominent bands that were smaller 372	  
than 48.5 kb. The results from the gel were reproducible (triplicate gels run; data not shown). 373	  
It is unsurprising that heating at 75ºC produced more complex banding patterns, as we would 374	  
expect the higher temperature to disassemble (some of) the capsids of VLPs resistant to 375	  
heating at 60ºC, thereby releasing packaged DNA. 376	  
Using this method, it was possible to visualize VLP DNA when stained with SYBR 377	  
Gold (Fig. 6) or ethidium bromide (Supplementary Fig. 3). It was clear that increasing the 378	  
temperature at which the samples were heated prior to loading onto the gel revealed greater 379	  
diversity in the samples, and that each individual harboured a unique VLP assemblage (Fig. 380	  
4). This is in agreement with the findings of the metagenomic studies of [11] and [12]. The 381	  
sample from Donor 6 did not reveal the same level of diversity as seen for the other donors, 382	  
Accepted version of Hoyles et al. (2014) Res Microbiol 165, 803–812. doi:10.1016/j.resmic.2014.10.006. 
	  
	  
18	  
in agreement with the results shown by TEM (Supplementary Fig. 1d). This donor’s sample 383	  
was predominated by “zeppelin”-like VLPs that may not have released their nucleid acids by 384	  
the conditions employed here. 385	  
Heating PEG-precipitated samples allowed us to generate PFGE images that 386	  
demonstrated that each individual harbours a unique VLP assemblage, and encouraged us to 387	  
continue with studies to improve recovery of VLP DNA from human faeces. It also showed 388	  
that our method of recovery of VLPs present in faeces was superior to that used previously 389	  
by [9] to generate a viral assemblage fingerprint. In that study, the authors stated that the 390	  
limited amount of DNA recovered using tangential flow filtration with a 500 g faecal sample 391	  
from a 33-year-old made it necessary to enhance the sample bands on the gel relative to the 392	  
ladder. In contrast, no enhancement of the bands detected by SYBR Gold (Fig. 6) or ethidium 393	  
bromide (Supplementary Fig. 3) was required using the methodology described herein, 394	  
although SYBR Gold was, as expected, far more sensitive than ethidium bromide. PEG 395	  
precipitation of VLPs present in 20 ml of FF, as used in this study, equates to the extraction 396	  
of VLPs from ~4 g faeces (sample losses are seen during filtration, and vary from donor to 397	  
donor due to the differences in viscosity of faecal supernatant obtained after removal of most 398	  
bacteria and debris from samples after centrifugation), with 50 µl of the resuspended PEG 399	  
precipitate representing VLPs isolated from ~200 mg of faeces. 400	  
The current study used a crude method of extracting DNA for PFGE. Using the 401	  
method of Rohozinski et al. [30], in which VLPs are embedded in agarose blocks, with CsCl-402	  
purified VLPs prior to heating may allow better ‘fingerprinting’ of VLPs in faecal samples. 403	  
This could, for example, be used as an inexpensive means of determining the effect of 404	  
freeze–thawing faecal samples prior to the recovery of VLPs from faecal samples. All of the 405	  
metagenomic studies conducted to date on the human faecal virome have used samples that 406	  
have been frozen prior to recovery of VLPs from samples. 407	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 408	  
3.4 Isolation of high-quality DNA from FFs 409	  
Reyes et al. [11] and Thurber et al. [15] (based on the work of [9]) have reported 410	  
recovery of ~500 ng (from 2–5 g of frozen faeces) and 500–3000 ng (from 500 g of fresh 411	  
faeces), respectively. The method of Reyes et al. [11] is closest to that presented herein for 412	  
the recovery of VLPs from faeces [i.e. they hand-filtered samples, whereas Breitbart et al. [9] 413	  
used tangential flow filtration to process their sample]. As stated above, 20 ml of FF equates 414	  
to ~4 g faeces. We processed 500 µl portions of 3.5–4 ml CsCl-purified VLPs for DNA 415	  
extraction, and resuspended the DNA in 50 µl of TE (Fig. 7). If we had processed the entire 416	  
PEG-precipitated, CsCl-purified VLP sample for each donor, we would have recovered 417	  
between ~1000 and 1800 ng from ~4 g of faeces (theoretically ~6000–11000 ng from 25 g of 418	  
faeces). This increase in recovery of DNA is thought to be mainly due to the use of 0.45 µm 419	  
filters rather than 0.22 µm filters to process samples, supported by our observation that 420	  
passing FFs through 0.22 µm filters led to VLP counts by EFM that were approximately half 421	  
of those of the 0.45 µm-filtered samples. Increasing filter size and using PEG precipitation to 422	  
increase the volume of sample that can be processed would allow greater sampling of the 423	  
faecal virome in future metagenomics studies. 424	  
In addition to demonstrating the utility of the method with faecal samples, we have 425	  
successfully isolated VLP DNA from human caecal effluent (Fig. 7). For each of the samples, 426	  
20 ml of 0.45 µm-filtered caecal filtrate prepared in LL was PEG-precipitated, with the VLPs 427	  
then purified on CsCl gradients. These 20-ml aliquots equated to ~4 ml caecal effluent from 428	  
each of the three samples examined. We started with 30, 30 and 10 ml, respectively, of 429	  
effluent from caecal samples L07 (healthy), L08 (no clinical data) and L10 (no clinical data). 430	  
Therefore, if the filtrate from entire homogenates of these samples had been processed, we 431	  
would have expected to isolate between ~600 and 8000 ng VLP DNA from caecal effluent. 432	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Consequently, it should be possible to conduct metagenomics studies of the VLP 433	  
assemblages associated with the human caecum using the methods described herein. 434	  
 435	  
3.5 Conclusions 436	  
We have presented a series of methods for enumerating and characterizing VLPs 437	  
present in human faecal and caecal samples. On the basis of enumeration of VLPs using 438	  
EFM, there are ~108 VLPs/ml FF, with faeces thought contain up to 1012 VLPs per gram of 439	  
sample. TEM analysis of faecal VLPs indicates that an individual is colonized by one 440	  
dominant bacteriophage family, with Myoviridae and Siphoviridae representing the main 441	  
families of bacteriophage detected in faeces. PFGE analysis of PEG-concentrated samples 442	  
has demonstrated that each individual harbours a unique VLP population, and that the 443	  
temperature at which samples are treated greatly affects diversity observed. Using 0.45 µm 444	  
filters to prepare samples, it is possible to isolate twice as much DNA as reported previously 445	  
from ~4 g of faeces. The inclusion of PEG precipitation in the methodology means that VLPs 446	  
from large volumes of FF can be concentrated, allowing recovery of microgram quantities of 447	  
VLP DNA from faecal samples. In addition, PEG precipitation and CsCl purification can be 448	  
used to recover VLPs from human caecal samples, with nanogram quantities of VLP DNA 449	  
being recovered from the processed samples. 450	  
 451	  
 452	  
453	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Fig. 1. Number of VLPs detected in FFs by using EFM. Values are shown as mean + SD (n = 531	  
2 per donor). Passing samples through a 0.22 µm filter reduced the number of VLPs present 532	  
in samples by approximately half (data not shown). White bars, per ml FF (faeces); grey bars, 533	  
per g faeces. 534	  
 535	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Fig. 2. Image showing faecal VLPs as they appear under an epifluorescence microscope 536	  
(×1000 magnification). Bacteriophages appear as ‘pinpricks’ of light when stained with 537	  
SYBR Gold. The brightest ‘pinpricks’ (black arrows) represent clusters of up to 30 VLPs. 538	  
The black dot (shown in the white circle) on the images is due to a scratch on the microscope 539	  
lens. (a) Contamination on filter, which gives an idea of the size and appearance of a 540	  
bacterium in comparison with VLPs. (b) Negative control, 0.1 µm-filtered, autoclaved H2O. 541	  
(c) Negative control, sterile 0.5 % ‘Lab-Lemco’/6 % NaCl. (d) Donor 1, 0.22 µm-filtered 542	  
sample; (e) Donor 1 0.45 µm-filtered sample. (f) Donor 2, 0.22 µm-filtered sample; (g) 543	  
Donor 2, 0.45 µm-filtered sample. Scale bar, 10 µm. 544	  
545	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Fig. 3. Transmission electron micrographs revealing the diversity of VLPs found in faeces. 545	  
(a) Donor 1 (female, 41 years) and (b) Donor 2 (female, 36 years) after extraction of VLPs in 546	  
TBT buffer. 547	  
548	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Fig. 4. Transmission electron micrographs of VLPs found in faeces of Donor 2 (female, 36 548	  
years) after extraction of VLPs in TBT buffer showing Myoviridae phages with radial 549	  
whiskers attached to the capsids (top) and clusters of Myoviridae phages adsorbing to 550	  
membrane vesicle material (bottom). 551	  
552	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Fig. 5. Transmission electron micrographs revealing the diversity of VLPs found in caecal 552	  
effluents. Sample (a) L08, (b) L10, (c) L16 and (d) L17 after extraction of VLPs in LL. No 553	  
clinical data were available for these individuals. 554	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Fig. 6. Use of PFGE to examine VLP populations in PEG-precipitated FFs (faeces), and 555	  
demonstration that increasing the temperature at which samples are heated prior to loading 556	  
onto the gel can affect the diversity uncovered. The gel was stained with SYBR Gold and 557	  
visualized as described in Methods. This is a crude (but inexpensive) method of examining 558	  
VLP populations in human faeces, and demonstrates that each individual harbours a unique 559	  
VLP profile. Ladder, lambda ladder (#340; New England Biolabs). 560	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Fig. 7. Isolation of high-quality DNA from CsCl-purified samples of human gastrointestinal 561	  
VLPs. VLP preparations were CsCl-purified and DNA extracted as described in Methods. 562	  
Aliquots (10 µl) of sample were run on a 0.8 % agarose gel at 90 V for 30 min. Lane 1, 563	  
molecular size ladder; lane 2, φKPLN1 positive control (a bacteriophage isolated from the 564	  
human caecum that infects Klebsiella pneumoniae subsp. pneumoniae K2 strains; L. Hoyles, 565	  
unpublished data), 63 ng DNA/µl; lane 3, VLP extract from faeces of Donor 4, 3.1 ng 566	  
DNA/µl; lane 4, VLP extract from faeces of Donor 3, 4.5 ng DNA/µl; lane 5, VLP extract 567	  
from caecal sample L07 (healthy), 0.2 ng DNA/µl; lane 6, VLP extract from caecal sample 568	  
L08 (no clinical data), 2.7 ng DNA/µl; lane 7, VLP extract from caecal sample L10 (no 569	  
clinical data), 3.8 ng DNA/µl. The two black arrows highlight the presence of RNA in the 570	  
sample from Donor 3, confirmed by treating the CsCl-purified sample with 20 µl of 1 mg/mL 571	  
RNAse A (bovine pancreas, ≥70 Kunitz/mg protein, prepared in 0.1 µm-filtered, sterile H2O) 572	  
with the DNAse in a second DNA extraction (not shown). VLPs and DNA were extracted 573	  
from human caecum samples (1:4 LL, v/v) as described in Methods as part of a study 574	  
examining the microbiota associated with the human caecum (L. Hoyles, unpublished data). 575	  
With the exception of the sample in lane 5, DNA visible to the naked eye was extracted from 576	  
all samples of gastrointestinal origin. 577	  
 578	  
